Cardiac Biomarkers and Their Role in Identifying Increased Risk of Cardiovascular Complications in COVID-19 Patients
Cardiovascular disease (CVD) is a global health concern, causing significant morbidity and mortality. Both lifestyle and genetics influence the development of CVD. It is often diagnosed late, when the treatment options are limited. Early diagnosis of CVD with help of biomarkers is necessary to preve...
Main Authors: | Nagendra Yaluri, Alena Stančáková Yaluri, Pavol Žeňuch, Zuzana Žeňuchová, Štefan Tóth, Peter Kalanin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/15/2508 |
Similar Items
-
Decreased 25-Hydroxy Vitamin D Level Is Associated with All-Cause Mortality in Patients with Type 2 Diabetes at High Cardiovascular Risk
by: Alena Stančáková Yaluri, et al.
Published: (2023-07-01) -
Serum biomarkers of cardiovascular complications in COVID-19
by: R. M. Gumerov, et al.
Published: (2021-07-01) -
Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
by: Farah Omran, et al.
Published: (2022-05-01) -
Circulating Myokines as Novel Biomarkers for Cardiovascular Diseases
by: Jin-xiu Lyu, et al.
Published: (2024-02-01) -
Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus
by: Agnieszka Bielska, et al.
Published: (2021-03-01)